https://orcid.org/0000-0002-7360-0491
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Seda Rençber, Fadime Aydın Köse & Sinem Yaprak Karavana. (2020) Dexamethasone loaded PLGA nanoparticles for potential local treatment of oral precancerous lesions. Pharmaceutical Development and Technology 25:2, pages 149-158.
Read now
Read now
Articles from other publishers (27)
Phuriwat Khiewkamrop, Chamraj Kaewraemruaen, Chonnavee Manipuntee, Chalathan Saengruengrit, Numpon Insin, Asada Leelahavanichkul, Warerat Kaewduangduen, Opor Sonpoung, Kasirapat Ariya-anandech, Nattiya Hirankarn & Patcharee Ritprajak. (2023) Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance. International Journal of Molecular Sciences 24:9, pages 8313.
Crossref
Crossref
Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang & Bo Jia. (2023) Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus. BioDrugs 37:3, pages 331-352.
Crossref
Crossref
Yue Lu, Dongfang Cheng, Baohua Niu, Xiuzhi Wang, Xiaxia Wu & Aiping Wang. (2023) Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research. Pharmaceuticals 16:3, pages 454.
Crossref
Crossref
Marian A. Ackun-Farmmer & Christopher M. Jewell. (2023) Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity. Advanced NanoBiomed Research 3:3, pages 2200135.
Crossref
Crossref
Sean T. Carey, Christopher Bridgeman & Christopher M. Jewell. (2023) Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps. Advanced Science 10:8.
Crossref
Crossref
Caiyun Liu, Jie Zhu, Yan Mi & Tao Jin. (2022) Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. Journal of Neuroinflammation 19:1.
Crossref
Crossref
Luke Tillman, Tanveer A. Tabish, Nazila Kamaly, Primrose Moss, Amal El-briri, Christoph Thiemermann, Md Zahidul I. Pranjol & Muhammad M. Yaqoob. (2022) Advancements in nanomedicines for the detection and treatment of diabetic kidney disease. Biomaterials and Biosystems 6, pages 100047.
Crossref
Crossref
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzieliene, Noushin Nabavi, Ali Dehshahri, Jomarien García-Couce, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, Pooyan Makvandi, Abbas Pardakhty, Abbas Aghaei Afshar & Ali Seyfoddin. (2022) Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomaterials Science & Engineering 8:5, pages 1763-1790.
Crossref
Crossref
He Li, Yong-Guang Yang & Tianmeng Sun. (2022) Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yiwei Liu & Takeshi Mori. (2022) Drug design for induction of antigen-specific immune tolerance抗原特異的な免疫寛容を誘導する医薬品の設計. Drug Delivery System 37:2, pages 142-148.
Crossref
Crossref
Sang-Hyun Kim, Ji-Hyun Park, Sun-Jae Lee, Hee-Sung Lee, Jae-Kyung Jung, Young-Ran Lee, Hyun-Il Cho, Jeong-Ki Kim, Kyungjae Kim, Chan-Su Park & Chong-Kil Lee. (2022) Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody. Immune Network 22:5.
Crossref
Crossref
Faezeh Dangkoub, Mojtaba Sankian, Mohsen Tafaghodi, Mahmoud Reza Jaafari & Ali Badiee. (2021) The impact of nanocarriers in the induction of antigen-specific immunotolerance in autoimmune diseases. Journal of Controlled Release 339, pages 274-283.
Crossref
Crossref
Jacob McCright, Ann Ramirez, Mayowa Amosu, Arnav Sinha, Amanda Bogseth & Katharina Maisel. (2021) Targeting the Gut Mucosal Immune System Using Nanomaterials. Pharmaceutics 13:11, pages 1755.
Crossref
Crossref
Jing Wen, Elizabeth B. Moloney, Aoife Canning, Ellen Donohoe, Thomas Ritter, Jiemin Wang, Daxiong Xiang, Junyong Wu & Yongjiang Li. (2021) Synthesized nanoparticles, biomimetic nanoparticles and extracellular vesicles for treatment of autoimmune disease: Comparison and prospect. Pharmacological Research 172, pages 105833.
Crossref
Crossref
Lin Zhou, Han Li, Xin-xue Zhang, Yang Zhao, Jing Wang, Li-chao Pan, Guo-sheng Du, Qiang He & Xian-liang Li. (2021) Rapamycin treated tol-dendritic cells derived from BM-MSCs reversed graft rejection in a rat liver transplantation model by inducing CD8+CD45RC−Treg. Molecular Immunology 137, pages 11-19.
Crossref
Crossref
David A. Horwitz, Sean Bickerton & Antonio La Cava. (2021) Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, Mariusz Skwarczynski & Istvan Toth. (2021) Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines. Vaccines 9:6, pages 563.
Crossref
Crossref
Jinwen Lin, Hongyi Wang, Chenxi Liu, Ao Cheng, Qingwei Deng, Huijuan Zhu & Jianghua Chen. (2021) Dendritic Cells: Versatile Players in Renal Transplantation. Frontiers in Immunology 12.
Crossref
Crossref
Noémi Anna Nagy, Aram M. de Haas, Teunis B. H. Geijtenbeek, Ronald van Ree, Sander W. Tas, Yvette van Kooyk & Esther C. de Jong. (2021) Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance. Frontiers in Immunology 12.
Crossref
Crossref
Daniela Placha & Josef Jampilek. (2021) Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 13:1, pages 64.
Crossref
Crossref
Anna Cifuentes-Rius, Anal Desai, Daniel Yuen, Angus P. R. Johnston & Nicolas H. Voelcker. (2020) Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nature Nanotechnology 16:1, pages 37-46.
Crossref
Crossref
F. Fontana, Z. Liu, J. Hirvonen & H.A. Santos. 2021. Porous Silicon for Biomedical Applications. Porous Silicon for Biomedical Applications
571
609
.
Andrew S. Ishizuka, Geoffrey M. Lynn & Christopher M. Jewell. 2021. Immunomodulatory Biomaterials. Immunomodulatory Biomaterials
139
173
.
Dongyoon Kim, Quoc-Viet Le, Yina Wu, Jinwon Park & Yu-Kyoung Oh. (2020) Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing. Pharmaceutics 12:12, pages 1233.
Crossref
Crossref
Quan Zhuang, Haozheng Cai, Qingtai Cao, Zixin Li, Shu Liu & Yingzi Ming. (2020) Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation. Frontiers in Immunology 11.
Crossref
Crossref
Fuping Shao, Mengmeng Zhang, Li Xu, Dengke Yin, Mengying Li, Qianqian Jiang, Qingqing Zhang & Ye Yang. (2019) Multiboosting of Cancer Immunotherapy by a Core–Shell Delivery System. Molecular Pharmaceutics 17:1, pages 338-348.
Crossref
Crossref
M.L. Formica, G.V. Ullio Gamboa, L.I. Tártara, J.D. Luna, J.P. Benoit & S.D. Palma. (2020) Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications. International Journal of Pharmaceutics 573, pages 118795.
Crossref
Crossref